These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1925165)

  • 21. Design and statistical issues in multicenter trials of severe head injury.
    Choi SC; Bullock R
    Neurol Res; 2001; 23(2-3):190-2. PubMed ID: 11320598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Rifkind BM
    Am J Cardiol; 1984 Aug; 54(5):30C-34C. PubMed ID: 6382999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and regression of coronary atherosclerosis. Is it safe and efficacious therapy?
    Montague T; Tsuyuki R; Burton J; Williams R; Dzavik V; Teo K
    Chest; 1994 Mar; 105(3):718-26. PubMed ID: 8131532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recruitment for clinical trials: the Lipid Research Clinics Coronary Primary Prevention Trial experience. Its implications for future trials.
    Circulation; 1982 Dec; 66(6 Pt 2):IV1-78. PubMed ID: 7127710
    [No Abstract]   [Full Text] [Related]  

  • 25. A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.
    Crow RA; Hart KA; McDermott MP; Tawil R; Martens WB; Herr BE; McColl E; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Hirtz D; Lochmuller H; Straub V; Ciafaloni E; Shieh PB; Spinty S; Childs AM; Manzur AY; Morandi L; Butterfield RJ; Horrocks I; Roper H; Flanigan KM; Kuntz NL; Mah JK; Morrison L; Darras BT; von der Hagen M; Schara U; Wilichowski E; Mongini T; McDonald CM; Vita G; Barohn RJ; Finkel RS; Wicklund M; McMillan HJ; Hughes I; Pegoraro E; Bryan Burnette W; Howard JF; Thangarajh M; Campbell C; Griggs RC; Bushby K; Guglieri M
    Trials; 2018 May; 19(1):291. PubMed ID: 29793540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of multicentre clinical trial data using adaptations of the Mosteller-Tukey procedure.
    Ciminera JL; Heyse JF; Nguyen HH; Tukey JW
    Stat Med; 1993 Jun; 12(11):1047-61. PubMed ID: 8341865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid-lowering for prevention of coronary heart disease: what policy now?
    Ul Haq I; Ramsay LE; Pickin DM; Yeo WW; Jackson PR; Payne JN
    Clin Sci (Lond); 1996 Oct; 91(4):399-413. PubMed ID: 8983865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome.
    Ravnskov U
    BMJ; 1992 Jul; 305(6844):15-9. PubMed ID: 1638188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid-lowering treatment in coronary artery disease: how low should cholesterol go?
    Jones PH
    Drugs; 2000 May; 59(5):1127-35. PubMed ID: 10852644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Lipid Research Clinics Coronary Primary Prevention Trial.
    L'Abbé KA; Detsky AS; Logan AG
    JAMA; 1985 Jun; 253(21):3091. PubMed ID: 3889392
    [No Abstract]   [Full Text] [Related]  

  • 31. Statistical considerations on design and analysis of bridging and multiregional clinical trials.
    Tsong Y
    J Biopharm Stat; 2012 Sep; 22(5):1078-80. PubMed ID: 22946952
    [No Abstract]   [Full Text] [Related]  

  • 32. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.
    Gordon DJ; Knoke J; Probstfield JL; Superko R; Tyroler HA
    Circulation; 1986 Dec; 74(6):1217-25. PubMed ID: 3536151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview of recruitment to the coronary primary prevention trial.
    Marshall GD
    Circulation; 1982 Dec; 66(6 Pt 2):IV5-9. PubMed ID: 7127722
    [No Abstract]   [Full Text] [Related]  

  • 34. Design, operation, and interpretation of clinical trials.
    Pihlstrom BL; Barnett ML
    J Dent Res; 2010 Aug; 89(8):759-72. PubMed ID: 20581353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central statistical monitoring: detecting fraud in clinical trials.
    Pogue JM; Devereaux PJ; Thorlund K; Yusuf S
    Clin Trials; 2013 Apr; 10(2):225-35. PubMed ID: 23283577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standard versus adaptive monitoring procedures: A commentary.
    Fleming TR
    Stat Med; 2006 Oct; 25(19):3305-12; discussion 3313-4, 3326-47. PubMed ID: 16850447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monitoring of clinical trials. Methodology, interim analyses, and end results].
    Pritsch M; Unnebrink K
    Med Klin (Munich); 1999 Dec; 94(12):712-7. PubMed ID: 10641517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary prevention of coronary disease with lipid-lowering drugs.
    Lancet; 1989 Mar; 1(8636):473-4. PubMed ID: 2563844
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NHLBI workshop on the Lipid Research Clinics Coronary Primary Prevention Trial.
    Arteriosclerosis; 1985; 5(4):397-403. PubMed ID: 3893403
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.